itf2984
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01871844)
Timeline
Indications
Mechanism of action
- Somatostatin receptor 3AGONIST
SSTR3 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- itf2984
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02111044 | Phase 2 | Apr 1, 2014 | Italfarmaco |
| NCT01897844 | Phase 1 | May 1, 2013 | Italfarmaco, University of Verona |
| NCT01871844 | Phase 1 | Jan 1, 2012 | Italfarmaco |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Italfarmaco | For profit | 3 | 3 | 2 | 2012 |
| University of Verona | Academic/Hospital | 1 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1